The Novodiag System*, high multiplex technology, precision engineered for simplicity, accuracy and affordability.
Optimise clinical testing and target priority patients with the Novodiag System, offering a broad and growing menu of high-multiplex and targeted assays to simplify molecular diagnostic testing for infectious diseases and antibiotic resistance.
Part of Hologic's Molecular Scalable Solutions, the Novodiag System streamlines laboratory workflow and delivers fast results and scalability.
For more information on how to deliver accurate results with clinical confidence on the Novodiag System.
Discover a Simplified Workflow
The Novodiag System offers high-performing and fully automated testing that delivers fast results. For higher throughput needs, gain the ability to test up to 16 samples simultaneously with Novodiag PLUS.
Be clinically confident with Smart technology that combines easy-to-use and versatile functionalities. The system is ready-to-use with no technical preparation and has user-friendly software with automated analysis, a clear display of results and different levels of access.
Optimise Lab Productivity
The Novodiag System offers a wide menu of high-multiplex and targeted assays in unitary cartridge-based format to simplify your molecular diagnostic testing.
Manage Antimicrobial Resistance
Novodiag CarbaR+ assay* aids in the detection of carbapenemases and colistin resistance.
- Improved patient care with the detection of 10 resistance genes
- Suited for both patient screening1 and epidemiological surveillance
- Fast infection control enabled2
Detect Gastroenteritis-causing Bacteria
Novodiag Bacterial GE+ assay* delivers on-demand testing of bacterial gastroenteritis.
- Accurate and wide detection of 14 pathogenic agents
- Improved diagnostic speed compared to traditional methods
- Significant improvement of time-to-result, compared to culture
Test for Stool Parasites
Novodiag Stool Parasites assay* detects protozoa, helminths and microsporidia leading to gastrointestinal complications.
- A comprehensive panel of 25 parasites
- Significant improvement of time-to-result and labour saving compared to traditional methods
- Streamline workflow for laboratory professionals3
Assays also available on the Novodiag System:
- Novodiag COVID-19 assay*
- Novodiag RESP-4 assay*
- Novodiag C. difficile assay*
Watch our Testimonial
Listen to Dr. Thierry Naas, Bacteriology Department at Hôpital Bicêtre AP-HP (Paris), discuss the benefits of the Novodiag System
The Novodiag System is part of Hologic’s Molecular Scalable Solutions
Giving labs of all shapes and sizes the power of choice.
With over 30 years of expertise, Hologic’s Molecular Scalable Solutions are designed to help meet the growing demands of your lab, today and in the future.
The decentralised, speciality and emergency testing delivered by the Novodiag System complements the centralised high-throughput testing offered by the Panther® System.
From a rapid single-patient result to population-level screening, Hologic’s Molecular Scalable Solutions meet the growing pressure and demands of today and tomorrow – all with the advantage of working with just one trusted partner.
Enhance your laboratory’s molecular testing capabilities with Smart Simplicity.
The menu is growing, and more assays are in development.
Contact us for more information about Novodiag
Please provide your details below to learn more about simplifying your syndromic, on-demand testing with the Novodiag System and range of assays.
References: 1. Novodiag CarbaR+ Instructions for use V2-0 - May 2022, Espoo, FINLAND: Mobidiag Ltd. 2022. 2. Shova S, Lister M, Mahida N. Evaluation of Novodiag CarbaR+ for the detection of carbapenemase producing organisms from faeces – NUH prevalence study 2020. 2020; FIS, [poster]. 3. Hartuis S, Lavergne R-A, Nourrisson C, et al. The Novodiag Stool Parasites assay, an innovative high-plex technique for fast detection of protozoa, helminths and microsporidia in stool samples: a retrospective and prospective study. Parasite. 2022;29: 27.
For Novodiag system and assay IFUs, please visit: https://eifu.mobidiag.com/mobidiag and for Panther system and assay IFUs, please visit: https://www.hologic.com/package-inserts
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium. EC REP details wherever applicable
*Product not available in the US
The Novodiag System*, high multiplex technology, precision engineered for simplicity, accuracy and affordability.
Optimise clinical testing and target priority patients with the Novodiag System, offering a broad and growing menu of high-multiplex and targeted assays to simplify molecular diagnostic testing for infectious diseases and antibiotic resistance.
Part of Hologic's Molecular Scalable Solutions, the Novodiag System streamlines laboratory workflow and delivers fast results and scalability.
For more information on how to deliver accurate results with clinical confidence on the Novodiag System.
Discover a Simplified Workflow
The Novodiag System offers high-performing and fully automated testing that delivers fast results. For higher throughput needs, gain the ability to test up to 16 samples simultaneously with Novodiag PLUS.
Be clinically confident with Smart technology that combines easy-to-use and versatile functionalities. The system is ready-to-use with no technical preparation and has user-friendly software with automated analysis, a clear display of results and different levels of access.
Optimise Lab Productivity
The Novodiag System offers a wide menu of high-multiplex and targeted assays in unitary cartridge-based format to simplify your molecular diagnostic testing.
Manage Antimicrobial Resistance
Novodiag CarbaR+ assay* aids in the detection of carbapenemases and colistin resistance.
- Improved patient care with the detection of 10 resistance genes
- Suited for both patient screening1 and epidemiological surveillance
- Fast infection control enabled2
Detect Gastroenteritis-causing Bacteria
Novodiag Bacterial GE+ assay* delivers on-demand testing of bacterial gastroenteritis.
- Accurate and wide detection of 14 pathogenic agents
- Improved diagnostic speed compared to traditional methods
- Significant improvement of time-to-result, compared to culture
Test for Stool Parasites
Novodiag Stool Parasites assay* detects protozoa, helminths and microsporidia leading to gastrointestinal complications.
- A comprehensive panel of 25 parasites
- Significant improvement of time-to-result and labour saving compared to traditional methods
- Streamline workflow for laboratory professionals3
Assays also available on the Novodiag System:
- Novodiag COVID-19 assay*
- Novodiag RESP-4 assay*
- Novodiag C. difficile assay*
The Novodiag System is part of Hologic’s Molecular Scalable Solutions
Giving labs of all shapes and sizes the power of choice.
With over 30 years of expertise, Hologic’s Molecular Scalable Solutions are designed to help meet the growing demands of your lab, today and in the future.
The decentralised, speciality and emergency testing delivered by the Novodiag System complements the centralised high-throughput testing offered by the Panther® System.
From a rapid single-patient result to population-level screening, Hologic’s Molecular Scalable Solutions meet the growing pressure and demands of today and tomorrow – all with the advantage of working with just one trusted partner.
Enhance your laboratory’s molecular testing capabilities with Smart Simplicity.
The menu is growing, and more assays are in development.
Contact us for more information about Novodiag
Please provide your details below to learn more about simplifying your syndromic, on-demand testing with the Novodiag System and range of assays.
References: 1. Novodiag CarbaR+ Instructions for use V2-0 - May 2022, Espoo, FINLAND: Mobidiag Ltd. 2022. 2. Shova S, Lister M, Mahida N. Evaluation of Novodiag CarbaR+ for the detection of carbapenemase producing organisms from faeces – NUH prevalence study 2020. 2020; FIS, [poster]. 3. Hartuis S, Lavergne R-A, Nourrisson C, et al. The Novodiag Stool Parasites assay, an innovative high-plex technique for fast detection of protozoa, helminths and microsporidia in stool samples: a retrospective and prospective study. Parasite. 2022;29: 27.
For Novodiag system and assay IFUs, please visit: https://eifu.mobidiag.com/mobidiag and for Panther system and assay IFUs, please visit: https://www.hologic.com/package-inserts
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium. EC REP details wherever applicable
*Product not available in the US